2020
DOI: 10.1016/j.rec.2019.10.004
|View full text |Cite
|
Sign up to set email alerts
|

Trends in cardiogenic shock management and prognostic impact of type of treating center

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
6
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 28 publications
1
6
0
1
Order By: Relevance
“…To our best knowledge, the presented study for the first time provides a clinical view from a national perspective on the impact of vascular access site on clinical outcomes in STEMI with CS in a contemporary unselected cohort of patients. Our analysis is consistent with the results of former studies [11,[19][20][21][22][23][24]. Favorable outcome in RA was confirmed in a large meta-analysis of 6 observational studies [11].…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…To our best knowledge, the presented study for the first time provides a clinical view from a national perspective on the impact of vascular access site on clinical outcomes in STEMI with CS in a contemporary unselected cohort of patients. Our analysis is consistent with the results of former studies [11,[19][20][21][22][23][24]. Favorable outcome in RA was confirmed in a large meta-analysis of 6 observational studies [11].…”
Section: Discussionsupporting
confidence: 92%
“…The absence of difference in bleeding complications between RA and FA might be partially explained by an impaired effect of oral antiplatelet agents related to diminished intestinal absorption in the setting of CS [21,23,24]. Furthermore, RA might reduce bleeding risk by limiting the number of femoral punctures needed in CS treatment [27][28][29].…”
Section: Discussionmentioning
confidence: 99%
“…This value is higher than those reported in the French registry (63%) in 2005 [ 5 ] and similar to those from the Italian study (83%) [ 10 ] in 2014. Both coronary revascularization procedures and the availability of an intensive cardiac care unit have been associated with lower mortality rates [ 8 ], although benefits in survival with the use of hemodynamic support devices (i.e., an intra-aortic balloon pump [ 11 ] or Impella support [ 20 , 21 ]) are as yet inconclusive. Furthermore, despite proper reperfusion, no differences in mechanical complications or ventricular arrhythmias were observed over the last 30 years.…”
Section: Discussionmentioning
confidence: 99%
“…CS is the leading cause of hospital mortality associated with acute myocardial infarction (MI). Prevalence of CS due to acute MI varies from 5 to 15% [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 ], although some of these data come from studies performed before the generalization of reperfusion [ 1 , 2 ]. Despite recent advances in the prevention and management of acute MI, and the widespread use of primary percutaneous coronary intervention in patients with ST-elevation MI (STEMI), acute phase mortality of STEMI-complicated CS (STEMI-CS) remains unacceptably high [ 6 , 7 , 8 , 9 , 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation